As filed with the Securities and Exchange Commission on July 30, 2024.
Registration No. 333-259751
Registration No. 333-262339
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
POST-EFFECTIVE
AMENDMENT NO. 3 TO:
Form S-1 Registration
No. 333-259751
POST-EFFECTIVE AMENDMENT NO. 1 TO:
Form S-1 Registration No. 333-262339
UNDER
THE
SECURITIES ACT OF 1933
eFFECTOR Therapeutics, Inc.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
| Delaware |
|
2834 |
|
85-3306396 |
| (State or other jurisdiction of
incorporation or organization) |
|
(Primary Standard Industrial
Classification Code Number) |
|
(I.R.S. Employer
Identification Number) |
124 Washington Street, Suite 101
Foxboro, MA 02035
(508) 543-1720
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Craig Jalbert
Chief
Executive Officer
124 Washington Street, Suite 101
Foxboro, MA 02035
(508) 543-1720
(Name, address, including zip code, and telephone number, including area code, of agent for service)
Copies to:
Cheston Larson
Matthew
T. Bush
Anthony Gostanian
Latham & Watkins LLP
12670 High Bluff Drive
San Diego, California
92130
(858) 523-5400
Approximate date of
commencement of proposed sale to the public: This post-effective amendment is being filed to deregister all of the unsold securities previously registered under the Registration Statements.
If any of the securities being registered on this form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of
1933 check the following box. ☒
If this form is filed to register additional securities for an offering pursuant to Rule 462(b) under the
Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
If this form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement for the same offering. ☐
If this form is a post-effective
amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated
filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
|
|
|
|
|
|
|
| Large accelerated filer |
|
☐ |
|
Accelerated filer |
|
☐ |
|
|
|
|
| Non-accelerated filer |
|
☒ |
|
Smaller reporting company |
|
☒ |
|
|
|
|
|
|
|
|
Emerging growth company |
|
☒ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐